Clinical Trial Update: Study to Evaluate a Potential PET Radioligand for Imaging Alpha-synuclein Deposits in the Brain [EARLY_Phase 1]

View source ↗

Summary

This clinical trial update reports the completion of an early-phase study evaluating a PET radioligand for imaging alpha-synuclein deposits in the brain, releva…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dementia with Lewy Bodies
• Multisystem Atrophy
• Parkinson Disease

Snippet

Sponsor: Invicro | Conditions: Alpha-Synucleinopathy, Parkinson's Disease | EARLY_Phase 1 | Status: COMPLETED